• NAME: EU-JAMRAI 2

  • FULL NAME: European Joint Action on Antimicrobial Resistance and Healthcare Associated Infections 2

  • PROJECT Nº:  101127787

  • FUNINCING ENTITY: European Health and Digital Executive Agency (HaDEA)

  • WEBPAGE:  https://eu-jamrai.eu/

  • DURATION: 1st of January 2024 till 31st of December 2028

  • PROJECT COORDINATION:  Institut Nacional de la Sante et de la Recherche medicale (Francia)

The mission of EU-JAMRAI 2 is to lead the fight against antimicrobial resistance (AMR) through joint and coordinated action across Europe.

Antimicrobial resistance (AMR) arises when bacteria, viruses, fungi and parasites change over time and become unresponsive to drugs, making infections more difficult to treat and increasing the risk of disease spread, severe forms of illness and death. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective, making infections increasingly difficult or impossible to treat. The consortium is committed to promoting interdisciplinary collaboration between countries, institutions and sectors to safeguard antimicrobial efficacy and protect public health, now and in the future.

EU-JAMRAI 2 is the continuation of the EU-JAMRAI joint action carried out between 2017-2021. In its first edition, EU-JAMRAI 1 aimed to help EU Member States develop effective One Health policies to combat antimicrobial resistance.

To follow up on the results achieved in EU-JAMRAI 1, EU-JAMRAI 2 now aims to support EU Member States in implementing specific measures to tackle AMR in order to improve the health of citizens.

  2. To provide direct and substantial support to assist Member States in developing and updating their National Antibiotic Resistance Plans (NARPs).
  3. To support the widespread adoption of state-of-the-art Infection Prevention and Control for both community-acquired and healthcare-associated infections, as well as antimicrobial stewardship strategies in a variety of settings.
  4. Strengthen the responsiveness and coordination of health systems to protect the population from AMR in the EU.
  5. Raise awareness and understanding of AMR across Europe.
  6. Promote the ‘One Health’ approach.
  7. Follow up on the EU-JAMRAI 1 policy recommendations and promote their implementation.
  8. To make Europe a region of good practice in AMR.

The Joint Action is composed of 10 Work Packages (WPs).

Four of them are cross-cutting: Coordination and management, evaluation, communication and dissemination, and awareness raising.

There are six other technical WPs: Member State Commitment, Antibiotic Stewardship, Infection Prevention and Control, Integrated One Health Surveillance, and Access to AMR-related diagnostic tools and products.

As results EU-JAMRAI 2 aims to, among other achievable results:

  • Marking AMR as a political priority
  • Implementation of the results in NAPs
  • Evidence-based recommendations for actions at national level
  • Implementation and expansion of the EARS-Vet and EARS-Env networks initiated in EU-JAMRAI 1
  • Improve the access to antibiotics in the EU
  • Evidence-based recommendations to share with the scientific community and carry out their implementation and dissemination.
  • Tools to educate the population (especially at school age) about AMR.

Biosistemak is leader of WP3: Evaluation together with FFIS (Fundación para la formación e investigación sanitarias de la Región de Murcia).

The evaluation of EU-JAMRAI 2 is composed on the one hand, by the Monitoring Plan whose objective is to measure the progression of the project, the activities carried out as well as the results obtained throughout the life of the project.

On the other hand, the design of an Impact Assessment Plan to measure the effects achieved thanks to the actions carried out in EU-JAMRAI 2.

Biosistemak represents the Basque Country in this Joint Action and participates in the project as an Affiliated Entity, the competent authority in Spain being the AEMPS (Spanish Agency of Medicines and Health Products).

Within the project, Biosistemak will lead the Evaluation work package together with the FFIS (Fundación para la formación e investigación sanitarias de la Región de Murcia).

Coordination: Nerea González, Maite Zabala, Dolores Verdoy, Ane Fullaondo.